1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Colitis, Ulcerative in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 20 (83.33) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Hafez, SMN; Abdel-Gaber, SA; Abdelmonaem, AA; Hafez, HM; Ibrahim, MA; Yehia Abdelzaher, W | 1 |
| Keuskamp, ZJ; Madretsma, GS; Van Dijk, JP; Zijlstra, FJ | 1 |
| Turnberg, LA; Wardle, TD | 1 |
| Braquet, P | 1 |
| Jewell, DP; Travis, SP | 1 |
| Chaussade, S; Couturier, D; Denizot, Y | 2 |
| Sandberg-Gertzén, H | 1 |
| Eliakim, R; Ferraris, L; Fiocchi, C; Karmeli, F; Klein, J; Rachmilewitz, D | 1 |
| Benveniste, J; Chaussade, S; Couturier, D; Guimbaud, R; Izzo, A; Martinolle, JP; Vidon, N | 1 |
| Hall, L; Turnberg, LA; Wardle, TD | 1 |
| Bohrer, A; Stenson, WF; Thyssen, E; Turk, J | 1 |
| Almer, S; Franzén, L; Kald, B; Ström, M; Tagesson, C | 1 |
| George, I; Itzkowitz, S; Lin, A; Mayer, L; Mehra, M; Ogata, S; Shim, J; Sperber, K | 1 |
| Hawkey, CJ; Jenkins, D; Stack, WA; Vivet, P | 1 |
| Carceller, E; Escamilla, I; Ferrando, R; Forn, J; García-Rafanell, J; Giral, M; Merlos, M; Ramis, J; Salas, J | 1 |
| Miwa, M; Nakamura, S; Nakamura, T; Sakaguchi, T; Sugatani, J; Unno, N | 1 |
| Eliakim, R; Karmeli, F; Ligumsky, M; Rachmilewitz, D; Simon, P | 1 |
| Chaussade, S; Denizot, Y | 1 |
| Benveniste, J; Chaussade, S; Colombel, JF; Couturier, D; Denizot, Y | 1 |
| Eliakim, R; Karmeli, F; Rachmilewitz, D | 1 |
| Benveniste, J; Chaussade, S; Couturier, D; Denizot, Y; Guerre, J; Hautefeuille, P; Nicoli, J; Raibaud, P; Valleur, P | 1 |
| Polonskiĭ, VM | 1 |
| Eliakim, R; Karmeli, F; Rachmilewitz, D; Razin, E | 1 |
5 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Colitis, Ulcerative
| Article | Year |
|---|---|
The role of platelet-activating factor in the pathogenesis of gastrointestinal disease.
Topics: Adjuvants, Immunologic; Animals; Cholestasis; Colitis, Ulcerative; Crohn Disease; Diarrhea; Digestive System Physiological Phenomena; Enterocolitis, Pseudomembranous; Epithelium; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Hypertension, Portal; Ischemia; Microcirculation; Pancreatitis; Peptic Ulcer; Platelet Activating Factor | 1994 |
[Fecal platelet-activating factor (PAF). A marker of digestive inflammatory disorders].
Topics: Bacterial Infections; Colitis, Ulcerative; Crohn Disease; Diarrhea; Feces; Humans; Platelet Activating Factor | 1993 |
[Mediators of inflammation and hemorrhagic rectocolitis].
Topics: Arachidonic Acids; Colitis, Ulcerative; Dinoprost; Dinoprostone; Eicosanoids; Gastrointestinal Motility; Humans; Leukotriene B4; Platelet Activating Factor | 1991 |
[Paf-acether and digestive tract].
Topics: Colitis, Ulcerative; Duodenal Ulcer; Humans; Ileitis; Platelet Activating Factor; Stomach Ulcer | 1991 |
[Platelet activating factor as a mediator of lesions of the digestive system].
Topics: Animals; Colitis, Ulcerative; Disease Models, Animal; Humans; Liver Cirrhosis, Experimental; Pancreatitis; Peptic Ulcer; Platelet Activating Factor; Rats | 1990 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Colitis, Ulcerative
| Article | Year |
|---|---|
An open trial of Cedemin, a Gingko biloba extract with PAF-antagonistic effects for ulcerative colitis.
Topics: Adult; Aged; Colitis, Ulcerative; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Platelet Activating Factor | 1993 |
Lack of effectiveness of the platelet-activating factor antagonist SR27417A in patients with active ulcerative colitis: a randomized controlled trial. The Platelet Activating Factor Antagonist Study Group in Ulcerative Colitis.
Topics: Adult; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Thiazoles | 1998 |
17 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Colitis, Ulcerative
| Article | Year |
|---|---|
Rupatadine ameliorated ulcerative colitis in rats via modulation of platelet-activatiweng factor/interleukin-6/vascular endothelial growth factor signalling pathway.
Topics: Acetic Acid; Animals; Antioxidants; Colitis, Ulcerative; Colon; Cyproheptadine; Histamine; Interleukin-6; Male; Platelet Activating Factor; Rats; Rats, Wistar; Signal Transduction; Vascular Endothelial Growth Factor A | 2022 |
Nicotine inhibits cytokine synthesis by mouse colonic mucosa.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Colitis, Ulcerative; Colon; Cytokines; Dinoprostone; Female; Interleukin-1; Intestinal Mucosa; Leukotriene B4; Leukotriene C4; Mice; Mice, Inbred BALB C; Nicotine; Platelet Activating Factor; Prostaglandins; Thromboxane B2; Tumor Necrosis Factor-alpha | 1995 |
Potential role for interleukin-1 in the pathophysiology of ulcerative colitis.
Topics: Adult; Animals; Colitis, Ulcerative; Colon; Culture Media; Culture Techniques; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; Interleukin-1; Intestinal Mucosa; Leukotriene C4; Male; Middle Aged; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinacrine; Rats; Rats, Sprague-Dawley | 1994 |
Cedemin, a Ginkgo biloba extract, should not be considered as a PAF antagonist.
Topics: Colitis, Ulcerative; Drugs, Chinese Herbal; Female; Humans; Male; Platelet Activating Factor | 1993 |
Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cells, Cultured; Child; Colitis, Ulcerative; Colon; Crohn Disease; Epithelium; Female; Humans; Ileum; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor | 1993 |
Intraluminal excretion of PAF, lysoPAF, and acetylhydrolase in patients with ulcerative colitis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Case-Control Studies; Colitis, Ulcerative; Colon; Female; Humans; Male; Perfusion; Peroxidase; Phospholipases A; Platelet Activating Factor | 1995 |
Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion.
Topics: Adult; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coculture Techniques; Colitis, Ulcerative; Colon; Culture Media, Conditioned; Cyclooxygenase Inhibitors; Dinoprostone; Electrophysiology; Female; Histamine; Humans; Intestinal Mucosa; Lipoxygenase Inhibitors; Male; Organ Culture Techniques; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serotonin | 1996 |
Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
Topics: Adult; Aged; Colitis, Ulcerative; Female; Gas Chromatography-Mass Spectrometry; Humans; Inflammation Mediators; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor; Reference Values | 1996 |
Concentrations of platelet activating factor in rectal mucosa in patients with ulcerative colitis.
Topics: Adult; Aged; Biopsy; Colitis, Ulcerative; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor; Proctoscopy; Rectum | 1996 |
Mucin secretion in inflammatory bowel disease: comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues.
Topics: Carbachol; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Epithelial Cells; Glycoproteins; Humans; In Vitro Techniques; Intestinal Secretions; Leukotriene C4; Macrophages; Mucins; Platelet Activating Factor; Tumor Cells, Cultured | 1998 |
Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
Topics: Amines; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aza Compounds; Azo Compounds; Colitis, Ulcerative; Drug Evaluation, Preclinical; Female; Hypotension; Imidazoles; Male; Mesalamine; Platelet Activating Factor; Platelet Aggregation; Prodrugs; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship; Trinitrobenzenesulfonic Acid | 2001 |
Relationship between the platelet activating factor acetylhydrolase gene and intractability of ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Drug Resistance; Female; Genotype; Humans; Hydrolases; Male; Middle Aged; Mutation; Platelet Activating Factor; Polymerase Chain Reaction; Severity of Illness Index; Steroids | 2002 |
Cytokines and platelet-activating factor in human inflamed colonic mucosa.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Calcimycin; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Imidazoles; Immunoglobulin E; Interleukin-1; Intestinal Mucosa; Mesalamine; Organ Culture Techniques; Platelet Activating Factor; Prednisolone; Sulfasalazine; Thiazoles | 1992 |
[Presence paf-acether mediator of inflammation in stools of patients with inflammatory enterocolitis].
Topics: Chromatography, High Pressure Liquid; Colitis, Ulcerative; Crohn Disease; Diarrhea; Feces; Humans; Platelet Activating Factor | 1991 |
Platelet-activating factor--a possible mediator in the pathogenesis of ulcerative colitis.
Topics: Aminosalicylic Acids; Cells, Cultured; Colitis, Ulcerative; Dose-Response Relationship, Drug; Humans; Ionophores; Mesalamine; Platelet Activating Factor; Prednisolone; Sulfasalazine | 1990 |
Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis.
Topics: Adult; Anal Canal; Anastomosis, Surgical; Colitis, Ulcerative; Feces; Female; Humans; Ileostomy; Ileum; Male; Platelet Activating Factor; Platelet Aggregation; Postoperative Complications | 1991 |
Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.
Topics: Adult; Aminosalicylic Acids; Calcimycin; Colitis, Ulcerative; Colon; Drug Combinations; Female; Glucosamine; Humans; Immunoglobulin E; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor; Prednisolone; Rectum; Sulfapyridine; Sulfasalazine | 1988 |